Apple and Consumers Revise $35 Million iPhone Audio Settlement Agreement
carol17
发表于 2024-6-22 09:40:32
1297
0
0
Apple and Consumer Revise $35 million iPhone Sound Settlement Agreement: Apple and consumer lawyers have updated a $35 million settlement agreement that will address allegations of poor sound quality and impaired call capabilities on iPhone 7 and 7 Plus phones sold by Apple. The Northern District Court of California in the United States initially approved the settlement agreement in November 2023. Consumers claim that a flaw in the iPhone reduces audio quality, making it difficult to make calls or use features such as Siri.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Boeing and US State Department reach a $51 million settlement agreement on illegal exports
- South Grid Energy Storage Technology and NIO Energy Sign an Agreement
- Photovoltaic energy storage leader announces signing of 3.5GW supply agreement!
- Apple announced that it will support call recording and audio transcription, and both parties will automatically receive prompts during calls
- AstraZeneca and Sinopharm Group reach nearly $2 billion cardiovascular drug authorization agreement
- Sanofi and private equity firm CD& R is negotiating to seek the sale of a controlling stake in the consumer health department
- Zhihu and Tencent renew framework agreement
- Beike terminates its agreement to acquire equity in Space Intelligence
- Kaken signs Stat6 global licensing agreement with Johnson&Johnson
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered